ArticleClinical, cosmetic and investigational dermatology2026
Evaluation of Atherosclerosis Risk in Patients with Psoriasis.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Psoriasis is a systemic inflammatory disease with a chronic course that is not limited to the skin. Atherosclerosis can cause serious cardiovascular events such as cerebrovascular stroke and myocardial infarction, which can result in death. This study aimed to examine the atherosclerosis risk in psoriasis patients by measuring the carotid intima media thickness (CIMT), an important marker of atherosclerosis. Methods: The study included 70 plaque psoriasis patients (41 male and 29 female) and 50 healthy volunteers (30 male and 20 female) between the ages of 18 and 65, from the Cukurova University Faculty of Medicine Department of Dermatology who did not use any systemic treatment in the previous 6 months. Clinical parameters were recorded. The presence of subclinical atherosclerosis was investigated by measuring carotid intima-media thickness (CIMT). CIMT was measured manually by the same cardiologist using B-mode ultrasonography. Results: The median value of the CIMT measured individuals in the patient group was 0.8 mm (min: 0.5-max:1.4), and individuals in the control group was 0.6 mm (min: 0.4-max: 0.95). CIMT value in the patient group was statistically significantly higher than in the control group (p<0.001). A statistically significant relationship was found between age, body mass index, cigarette use, waist and hip circumference, HBA1C, total cholesterol, triglycerides, duration. In multivariate linear regression analysis, cigarette use (p = 0.001) and disease duration (p = 0.024) remained significant, while the Psoriasis Area and Severity Index (PASI) showed a trend toward significance (p = 0.071). Conclusion: Our study revealed that CIMT value increases in psoriasis patients. It can be said that this increase in CIMT is more serious in the presence of PASI, disease duration and smoking. In conclusion, psoriasis patients-especially those who smoke and those with a longer disease duration-should be regularly investigated and followed up for atherosclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.